Angiogenesis and Anti-Angiogenic Treatment in Prostate Cancer: Mechanisms of Action and Molecular Targets
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiogenesis and Anti-Angiogenic Treatment in Prostate Cancer: Mechanisms of Action and Molecular Targets
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 18, Pages 9926
Publisher
MDPI AG
Online
2021-09-15
DOI
10.3390/ijms22189926
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prostate cancer hijacks the microenvironment
- (2021) Phillip Thienger et al. NATURE CELL BIOLOGY
- Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2021) Marcia S Brose et al. LANCET ONCOLOGY
- Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
- (2021) Oliver Sartor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unraveling the Wide Spectrum of Melanoma Biomarkers
- (2021) Antonios Revythis et al. Diagnostics
- Role of VEGFs/VEGFR-1 Signaling and Its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models
- (2020) Claudia Ceci et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exosomes secreted by prostate cancer cells under hypoxia promote matrix metalloproteinases activity at pre‐metastatic niches
- (2020) Gagan Deep et al. MOLECULAR CARCINOGENESIS
- Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: Results of cohort 6 of the COSMIC-021 study.
- (2020) Neeraj Agarwal et al. JOURNAL OF CLINICAL ONCOLOGY
- CDCA2 Inhibits Apoptosis and Promotes Cell Proliferation in Prostate Cancer and Is Directly Regulated by HIF-1α Pathway
- (2020) Yixiang Zhang et al. Frontiers in Oncology
- On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?
- (2020) Adilson Fonseca Teixeira et al. Frontiers in Cell and Developmental Biology
- An Update on the Prognostic and Predictive Serum Biomarkers in Metastatic Prostate Cancer
- (2020) Helen Saxby et al. Diagnostics
- Wise Management of Ovarian Cancer: On the Cutting Edge
- (2020) Stergios Boussios et al. Journal of Personalized Medicine
- The Genetic Complexity of Prostate Cancer
- (2020) Eva Compérat et al. Genes
- Increased Expressions of Matrix Metalloproteinases (MMPs) in Prostate Cancer Tissues of Men with Type 2 Diabetes
- (2020) Andras Franko et al. Biomedicines
- Nanoliposomal formulation encapsulating celecoxib and genistein inhibiting COX-2 pathway and Glut-1 receptors to prevent prostate cancer cell proliferation
- (2019) Jingyan Tian et al. CANCER LETTERS
- COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesis
- (2019) Yu Zheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Angiogenesis in Prostate Cancer
- (2019) Zsombor Melegh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
- (2019) Kim N. Chi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prostate cancer cells enhance interleukin-15-mediated expansion of NK cells
- (2019) Christina Sakellariou et al. BJU INTERNATIONAL
- MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis
- (2019) H. Q. Mu et al. Clinical & Translational Oncology
- Association between interleukin-8 rs4073 polymorphism and prostate cancer: A meta-analysis
- (2019) Chih-Heng Chen et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- The microRNA signatures: aberrantly expressed miRNAs in prostate cancer
- (2018) N. Sharma et al. Clinical & Translational Oncology
- Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update
- (2018) Toni K. Choueiri et al. EUROPEAN JOURNAL OF CANCER
- New Insights in Anti-Angiogenesis in Multiple Myeloma
- (2018) Domenico Ribatti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-guided gene expression in prostate cancer: Literature and database overview
- (2018) Olga E. Bryzgunova et al. JOURNAL OF GENE MEDICINE
- Interleukin-6 and prostate cancer: Current developments and unsolved questions
- (2018) Zoran Culig et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication
- (2018) Christopher C. Kloss et al. MOLECULAR THERAPY
- COX-2 mediates pro-tumorigenic effects of PKCε in prostate cancer
- (2018) Rachana Garg et al. ONCOGENE
- Itraconazole as a Non-Castrating Treatment for Biochemically Recurrent Prostate Cancer: a Phase 2 Study
- (2018) Mina Lee et al. Clinical Genitourinary Cancer
- Roles of microRNA in prostate cancer cell metabolism
- (2018) Khanmi Kasomva et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint
- (2018) Ethan M. Basch et al. EUROPEAN UROLOGY
- Diagnostic Performance of Prostate Imaging Reporting and Data System Version 2 for Detection of Prostate Cancer: A Systematic Review and Diagnostic Meta-analysis
- (2017) Sungmin Woo et al. EUROPEAN UROLOGY
- Prostate cancer: Cabozantinib activates innate immunity
- (2017) Peter Sidaway Nature Reviews Urology
- Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
- (2017) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
- (2017) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Matrix Metalloproteinases: A challenging paradigm of cancer management
- (2017) Ali Alaseem et al. SEMINARS IN CANCER BIOLOGY
- Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity
- (2017) Akash Patnaik et al. Cancer Discovery
- Nonsteroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk: results from the EPICAP study
- (2017) Solene Doat et al. Cancer Medicine
- Imaging Locally Advanced, Recurrent, and Metastatic Prostate Cancer
- (2017) Maria L. Lindenberg et al. JAMA Oncology
- Phase II trial of cediranib (AZD2171) in docetaxel-resistant, castrate-resistant prostate cancer (CRPC)
- (2017) J. J. Karakunnel et al. JOURNAL OF CLINICAL ONCOLOGY
- Intensity-modulated radiotherapy reduces toxicity with similar biochemical control compared with 3-dimensional conformal radiotherapy for prostate cancer: A randomized clinical trial
- (2016) Gustavo Arruda Viani et al. CANCER
- Role of taxanes in advanced prostate cancer
- (2016) J. Cassinello et al. Clinical & Translational Oncology
- Prognostic Value of the Cell Cycle Progression Score in Patients with Prostate Cancer: A Systematic Review and Meta-analysis
- (2016) Silvia Sommariva et al. EUROPEAN UROLOGY
- The Potential of MicroRNAs as Prostate Cancer Biomarkers
- (2016) Linda Fabris et al. EUROPEAN UROLOGY
- PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
- (2016) Jeffrey C. Weinreb et al. EUROPEAN UROLOGY
- A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score
- (2016) Jonathan I. Epstein et al. EUROPEAN UROLOGY
- Prostate Cancer, Version 1.2016
- (2016) James L. Mohler et al. Journal of the National Comprehensive Cancer Network
- Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
- (2016) Toni K Choueiri et al. LANCET ONCOLOGY
- Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition
- (2016) Q Zhang et al. ONCOGENE
- TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB
- (2016) Cachétne S.X. Barrett et al. PROSTATE
- The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
- (2015) Jonathan I. Epstein et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Lenalidomide in Treating Patients with Castration-Resistant Prostate Cancer
- (2015) Dong-Liang Xing et al. Asian Pacific Journal of Cancer Prevention
- Expectant management for men with early stage prostate cancer
- (2015) Christopher P. Filson et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone
- (2015) Pierrick G.J. Fournier et al. CANCER CELL
- MicroRNA in prostate cancer
- (2015) Kasomva Khanmi et al. CLINICA CHIMICA ACTA
- Acute Toxicity After Image-Guided Intensity Modulated Radiation Therapy Compared to 3D Conformal Radiation Therapy in Prostate Cancer Patients
- (2015) Ruud C. Wortel et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial
- (2015) Daniel P Petrylak et al. LANCET ONCOLOGY
- Teriflunomide (Leflunomide) Promotes Cytostatic, Antioxidant, and Apoptotic Effects in Transformed Prostate Epithelial Cells: Evidence Supporting a Role for Teriflunomide in Prostate Cancer Chemoprevention
- (2015) Numsen Hail et al. NEOPLASIA
- Anti-angiogenesis in prostate cancer: knocked down but not out
- (2014) Yu-Ning Wong et al. ASIAN JOURNAL OF ANDROLOGY
- A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancer
- (2014) Arun A. Azad et al. INVESTIGATIONAL NEW DRUGS
- Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?
- (2014) John T. Wei et al. JOURNAL OF CLINICAL ONCOLOGY
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
- (2014) Tomasz M. Beer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammation and prostate cancer: the role of interleukin 6 (IL-6)
- (2013) Daniel P. Nguyen et al. BJU INTERNATIONAL
- Head-to-Head Comparison of Prostate Health Index and Urinary PCA3 for Predicting Cancer at Initial or Repeat Biopsy
- (2013) Vincenzo Scattoni et al. JOURNAL OF UROLOGY
- Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial
- (2013) Ian F Tannock et al. LANCET ONCOLOGY
- Targeting prostate tumour angiogenesis with cediranib
- (2013) Sarah Payton Nature Reviews Urology
- Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate Cancer
- (2013) E. S. Antonarakis et al. ONCOLOGIST
- Tyrosine Kinase Blockers: New Hope for Successful Cancer Therapy
- (2012) Dariusz Pytel et al. Anti-Cancer Agents in Medicinal Chemistry
- Systematic Review and Meta-analysis of Studies Reporting Potency Rates After Robot-assisted Radical Prostatectomy
- (2012) Vincenzo Ficarra et al. EUROPEAN UROLOGY
- Systematic Review and Meta-analysis of Studies Reporting Urinary Continence Recovery After Robot-assisted Radical Prostatectomy
- (2012) Vincenzo Ficarra et al. EUROPEAN UROLOGY
- Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401
- (2012) William Kevin Kelly et al. JOURNAL OF CLINICAL ONCOLOGY
- Early changes in apparent diffusion coefficients predict radiosensitivity of human nasopharyngeal carcinoma xenografts
- (2012) Jianji Pan et al. LARYNGOSCOPE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Contrasted effects of the multitarget TKi vandetanib on docetaxel-sensitive and docetaxel-resistant prostate cancer cell lines
- (2012) Olivier Guérin et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Targeted Therapy of VEGFR2 and EGFR Significantly Inhibits Growth of Anaplastic Thyroid Cancer in an Orthotopic Murine Model
- (2011) M. K. Gule et al. CLINICAL CANCER RESEARCH
- Phase II Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
- (2011) Roberto Pili et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab enhances the therapeutic efficacy of Irinotecan against human head and neck squamous cell carcinoma xenografts
- (2011) Shousong Cao et al. ORAL ONCOLOGY
- Study of matrix metalloproteinases and their inhibitors in prostate cancer
- (2010) S Escaff et al. BRITISH JOURNAL OF CANCER
- A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands
- (2010) A Gupta et al. BRITISH JOURNAL OF CANCER
- A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cancer
- (2010) Joel Picus et al. CANCER
- VEGF and prostatic cancer: a systematic review
- (2010) Francisco Botelho et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Phase II Trial of Bevacizumab, Thalidomide, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer
- (2010) Yang-Min Ning et al. JOURNAL OF CLINICAL ONCOLOGY
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fibroblast Growth Factors: Biology, Function, and Application for Tissue Regeneration
- (2010) Ye-Rang Yun et al. Journal of Tissue Engineering
- Angiogenesis Inhibition in Prostate Cancer: Current Uses and Future Promises
- (2010) Jeanny B. Aragon-Ching et al. Journal of Oncology
- Phase II study of sunitinib in men with advanced prostate cancer
- (2009) M. Dror Michaelson et al. ANNALS OF ONCOLOGY
- Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer
- (2009) O Bratt et al. BRITISH JOURNAL OF CANCER
- A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel/Prednisolone in Patients with Hormone-Refractory Prostate Cancer
- (2009) József Horti et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- A Phase I Study of Sunitinib plus Bevacizumab in Advanced Solid Tumors
- (2009) B. I. Rini et al. CLINICAL CANCER RESEARCH
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
- (2009) G L Semenza ONCOGENE
- A Phase II Clinical Trial of Sorafenib in Androgen-Independent Prostate Cancer
- (2008) W. L. Dahut et al. CLINICAL CANCER RESEARCH
- Combination of Bevacizumab and Docetaxel in Docetaxel-Pretreated Hormone-Refractory Prostate Cancer: A Phase 2 Study
- (2008) Giuseppe Di Lorenzo et al. EUROPEAN UROLOGY
- Role of platelet-derived growth factors in physiology and medicine
- (2008) J. Andrae et al. GENES & DEVELOPMENT
- Hormone-refractory prostate cancer responding to bevacizumab
- (2008) Stefano Iacobelli INTERNATIONAL JOURNAL OF UROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started